What Is UFE?
Uterine fibroid embolization, also called uterine artery embolization for fibroids, is an image-guided procedure that reduces blood flow to fibroids by blocking small uterine artery branches. Without their usual blood supply, fibroids often shrink over time and symptoms may improve.
UFE is most commonly considered for symptoms such as heavy menstrual bleeding, prolonged bleeding, pelvic pressure, urinary frequency, bloating, pain, or bulk symptoms related to fibroids. It is not performed simply because fibroids are present on ultrasound; many fibroids do not require treatment.
The procedure is usually performed by an interventional radiologist, but assessment should involve gynecology because fibroid symptoms can overlap with adenomyosis, endometriosis, abnormal uterine bleeding from other causes, ovarian conditions, or malignancy in rare cases.
Why Do Patients Consider UFE?
Patients may consider UFE when symptoms affect daily life and they wish to avoid hysterectomy or myomectomy, are not ideal surgical candidates, have multiple fibroids, or prefer a uterine-sparing approach. UFE may also be considered when medical therapy is ineffective, not tolerated, or not desired long-term.
The words uterine-sparing do not automatically mean fertility-preserving. Pregnancy after UFE is possible in some patients, but fertility goals require careful discussion with gynecology and fertility specialists because myomectomy may be preferred in selected patients who strongly desire future pregnancy.
Treatment planning should focus on the patient’s symptoms and goals. A patient whose main problem is heavy bleeding may have a different best option from a patient whose main issue is pressure, infertility, recurrent pregnancy loss, or pelvic pain from another diagnosis.
Assessment Before UFE
Pre-treatment assessment usually includes gynecologic evaluation, pelvic ultrasound, and often pelvic MRI. MRI helps define fibroid number, size, location, vascularity, degeneration, adenomyosis, and other pelvic findings that may influence the treatment plan.
The team may review menstrual history, anemia, pregnancy plans, previous pelvic surgery, Pap smear status, endometrial sampling when indicated, hormonal therapy, contraceptive use, and risk factors for malignancy. Heavy bleeding should not automatically be assumed to be caused only by fibroids.
Patients should be informed about alternatives such as medication, hormonal intrauterine device, myomectomy, hysterectomy, radiofrequency ablation, focused ultrasound, or observation depending on symptoms and goals.
Fibroid Type, Location, and Symptom Fit
Submucosal, intramural, subserosal, pedunculated, cervical, and very large fibroids may behave differently and may respond differently to treatment. A fibroid causing heavy bleeding may require a different discussion from a fibroid causing pressure, urinary frequency, or infertility.
MRI can help determine whether symptoms match fibroid location and whether adenomyosis or another pelvic condition may be contributing. This is especially important when pain is the main complaint.
Fertility, Pregnancy, and Ovarian Function
Patients who want future pregnancy should receive individualized counseling before UFE. Some may still choose UFE after understanding the trade-offs, while others may be guided toward myomectomy, medical management, fertility treatment, or observation.
Age, ovarian reserve, fibroid location, pregnancy history, and reproductive goals all influence the discussion. The decision should not be simplified into a universal rule.
Ovarian function is also relevant, especially in patients approaching menopause or those with reduced ovarian reserve. Patients should understand possible menstrual changes before treatment.
When Further Gynecologic Evaluation Is Needed
Very heavy bleeding, rapidly changing symptoms, postmenopausal bleeding, unusual imaging features, endometrial abnormalities, or anemia may require additional gynecologic investigation before embolization.
The goal is not to delay care unnecessarily, but to make sure fibroids are truly the correct treatment target and that a more serious diagnosis is not missed.
Anemia and Pre-Procedure Optimization
Patients with heavy menstrual bleeding may have iron deficiency or anemia before UFE. Correcting anemia, reviewing iron therapy, and planning bleeding control can improve safety and recovery. Severe anemia may need treatment before elective travel.
Blood count results should be recent, and patients should know whether they need iron, hormonal medication, transfusion assessment, or gynecology input before embolization.
Preparing for UFE Abroad
Pelvic MRI and ultrasound reports with actual imaging files
Gynecology consultation notes and bleeding history
Blood count and iron studies if heavy bleeding or anemia is present
Pregnancy test when appropriate and pregnancy plans discussion
Medication list including blood thinners and hormonal treatments
Plan for pain control, post-embolization monitoring, and follow-up gynecology care
Patients travelling internationally should understand that the early recovery period can involve significant cramping and fatigue. Travel timing should allow for monitoring, pain control, and medical review before returning home.
How Is UFE Performed?
UFE is usually performed through a small arterial access site in the wrist or groin. The interventional radiologist guides a catheter into the uterine arteries using fluoroscopy and contrast.
Small particles are injected to reduce blood flow to the fibroids. Both uterine arteries are typically treated because fibroids often receive blood supply from both sides. The procedure endpoint is determined by blood flow changes seen during angiography.
Pain management is an important part of UFE. Hospitals may use anti-inflammatory medication, pain medication, nerve blocks, patient-controlled analgesia, or other protocols depending on local practice.
Recovery After UFE
Cramping pain, pelvic pressure, nausea, low-grade fever, fatigue, and vaginal discharge can occur after UFE. These symptoms are often part of post-embolization recovery but should still be monitored according to discharge instructions.
Many patients return gradually to routine activities over days to a couple of weeks, but recovery varies. Heavy lifting, intense exercise, sexual activity, and travel should follow the treating doctor’s guidance.
Fibroid shrinkage and symptom improvement develop over months rather than overnight. Bleeding may improve earlier than bulk symptoms, but each patient responds differently.
Discharge Planning and Post-Embolization Symptoms
Post-embolization cramping can be intense during the early recovery period. A clear pain control plan, nausea plan, hydration advice, and warning signs are essential. Patients staying in a hotel after treatment should know how to reach the hospital and when to return for assessment.
Discharge advice should also explain vaginal discharge, expected bleeding changes, fever thresholds, and symptoms that may suggest infection or fibroid passage.
Results and Long-Term Follow-Up
UFE aims to reduce fibroid-related symptoms, not remove the uterus or physically remove the fibroids. Fibroids usually shrink and become less symptomatic, but they remain in the uterus as treated tissue.
Follow-up may include symptom review, blood count monitoring if anemia was present, gynecology review, and repeat imaging when recommended. New fibroids or persistent symptoms may require further evaluation.
Patients should understand how UFE may affect menstruation, fertility, ovarian function, and future pelvic imaging. Age and baseline ovarian reserve may influence risk of menstrual changes.
Risks and Possible Complications
Pain, cramping, nausea, fever, fatigue, or post-embolization symptoms
Infection, endometritis, or rare need for urgent surgery
Vaginal discharge or passage of fibroid tissue in selected cases
Temporary or permanent menstrual changes, including ovarian function changes
Non-target embolization, arterial injury, bleeding, or contrast reaction
Persistent symptoms or need for additional treatment
Planning UFE Abroad Responsibly
UFE abroad should be planned with both interventional radiology and gynecology input. It is especially important to clarify fertility goals, exclude other causes of bleeding, and ensure that post-procedure care is available after returning home.
Patients should receive procedure details, materials used, pain medication plan, warning symptoms, expected recovery timeline, and follow-up recommendations. These records should be shared with their gynecologist.
Questions to Clarify Before UFE
Do symptoms match fibroid findings on MRI or ultrasound?
Has abnormal bleeding been evaluated appropriately?
Are fertility or pregnancy goals part of decision-making?
Is adenomyosis or another pelvic condition also present?
What pain control plan will be used after embolization?
When should gynecology follow-up and repeat imaging occur?
How Healing Journey Supports UFE Patients
For UFE patients, we help coordinate gynecology records, pelvic MRI, blood count results, medication review, and interventional radiology assessment before treatment. This helps confirm that fibroids are the correct target and that the patient understands alternatives.
After UFE, we help organize discharge instructions, pain management information, warning symptoms, follow-up timing, and communication with the home gynecologist. This is especially valuable when anemia, fertility questions, or complex pelvic symptoms are present.
What Patients Should Not Assume About UFE
Patients should not assume that every fibroid-related symptom will improve after embolization. Bleeding, pressure, pain, fertility concerns, and anemia may have different causes and may respond differently.
Patients should also not assume that UFE and myomectomy are interchangeable. Each option has different implications for recovery, fertility, recurrence, symptom control, and long-term gynecologic care.
How UFE Differs from Myomectomy and Hysterectomy
UFE, myomectomy, and hysterectomy are not interchangeable treatments. UFE reduces blood supply to fibroids and usually leaves treated fibroid tissue in the uterus. Myomectomy removes selected fibroids while preserving the uterus. Hysterectomy removes the uterus and is definitive for uterine fibroids but has different implications for recovery, fertility, hormones, and patient preference.
The best option depends on age, symptoms, fibroid number, fibroid location, uterine size, fertility goals, anemia, previous surgery, adenomyosis, and the patient’s tolerance for recurrence risk or future treatment. A patient with heavy bleeding and multiple intramural fibroids may have a different pathway from a patient with a submucosal fibroid and pregnancy goals.
Why MRI Can Change the Recommendation
Pelvic MRI can show details that ultrasound may not fully define, including adenomyosis, fibroid degeneration, pedunculated fibroids, endometrial cavity distortion, ovarian findings, and other pelvic conditions. These findings can change whether UFE is appropriate, whether gynecology investigation is needed first, or whether another treatment may be better.
For international patients, MRI also helps the interventional radiologist plan whether the fibroids are likely to respond and whether symptom patterns match the anatomy. Sending only a short ultrasound report may not be enough for a reliable recommendation.
Menstrual Changes and Long-Term Expectations
After UFE, periods may become lighter, cramping may change, and bulk symptoms may improve gradually. Some patients experience temporary menstrual disruption; a smaller group may have longer-term ovarian function changes, particularly depending on age and baseline ovarian reserve. These possibilities should be discussed before treatment.
Patients should also understand that UFE does not prevent all future gynecologic problems. New fibroids, persistent adenomyosis-related symptoms, endometrial issues, or unrelated pelvic pain may still require care later.
المراجع
- Society of Interventional Radiology (SIR). Quality improvement guidance and patient resources on uterine fibroid embolization.
- American College of Radiology (ACR). Appropriateness Criteria for management of uterine fibroids.
- CIRSE patient information and standards resources on uterine artery embolization.
- Royal College of Obstetricians and Gynaecologists and Royal College of Radiologists guidance on uterine artery embolisation.
- British Society of Interventional Radiology (BSIR). Patient information on uterine artery embolisation.
Uterine Fibroid Embolization (UFE) FAQs
Does UFE remove fibroids?
No. UFE blocks blood supply so fibroids usually shrink and symptoms may improve. The fibroids are not surgically removed.
Can I have UFE if I want pregnancy later?
This requires individualized gynecology and fertility discussion. UFE may not be the preferred option for every patient who strongly desires future pregnancy.
How painful is recovery?
Cramping can be significant in the first days. Pain control planning is an important part of UFE care.
How long until symptoms improve?
Bleeding may improve within cycles, while bulk symptoms often improve over several months as fibroids shrink.
Will fibroids come back?
Treated fibroids often shrink, but new fibroids or persistent symptoms can occur. Follow-up is important.
